Cargando…
A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
SIMPLE SUMMARY: The gold standard for genetic panel test samples is considered to be tissue specimens. However, in clinical practice, tissue specimens are often unavailable. Therefore, using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367394/ https://www.ncbi.nlm.nih.gov/pubmed/35954448 http://dx.doi.org/10.3390/cancers14153784 |
_version_ | 1784765790544723968 |
---|---|
author | Morikawa, Kei Kida, Hirotaka Handa, Hiroshi Inoue, Takeo Saji, Hisashi Koike, Junki Nakamura, Seiji Sato, Yoshiharu Ueda, Yumi Suzuki, Fumihiko Matoba, Ryo Mineshita, Masamichi |
author_facet | Morikawa, Kei Kida, Hirotaka Handa, Hiroshi Inoue, Takeo Saji, Hisashi Koike, Junki Nakamura, Seiji Sato, Yoshiharu Ueda, Yumi Suzuki, Fumihiko Matoba, Ryo Mineshita, Masamichi |
author_sort | Morikawa, Kei |
collection | PubMed |
description | SIMPLE SUMMARY: The gold standard for genetic panel test samples is considered to be tissue specimens. However, in clinical practice, tissue specimens are often unavailable. Therefore, using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we enrolled patients who underwent diagnostic procedures to evaluate analysis accuracy, nucleic acid yield, and quality using cytological specimens. Cytological specimens were suitable for both nucleic acid yield and specimen quality due to the ease of collection and processing. Cytological sample analysis detected gene mutations in 68.7% of lung adenocarcinomas, and these samples were consistent with companion diagnostic tests 99.5% of the time. Moreover, the allele frequency of gene mutations in cytological specimens showed a high correlation with tissue specimens. This is the first study to prospectively evaluate the feasibility of a lung cancer gene panel test using cytological specimens. ABSTRACT: Background: Genetic panel tests require sufficient tissue samples, and therefore, cannot always be performed. Although collecting cytological specimens is easier than tissue collection, there are no validation studies on the diagnostic accuracy of lung cancer gene panel tests using cytology samples. Methods: Using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we prospectively enrolled consecutive patients who underwent diagnostic procedures. We evaluated the analysis accuracy rate, nucleic acid yield, and the quality of cytological specimens under brushing, needle aspiration, and pleural effusion. We then compared these specimens with collected tissue samples. Results: In 163 prospectively enrolled cases, nucleic acid extraction and analysis accuracy was 100% in cases diagnosed with adenocarcinoma. Gene mutations were found in 68.7% of cases with 99.5% (95% CI: 98.2–99.9) concordance to companion diagnostics. The median DNA/RNA yield and DNA/RNA integrity number were 475/321 ng and 7.9/5.7, respectively. The correlation coefficient of the gene allele ratio in 64 cases compared with tissue samples was 0.711. Conclusion: The success of gene analysis using cytological specimens was high, and the yield and quality of the extracted nucleic acid were sufficient for panel analysis. Moreover, the allele frequency of gene mutations in cytological specimens showed high correlations with tissue specimens. |
format | Online Article Text |
id | pubmed-9367394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93673942022-08-12 A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens Morikawa, Kei Kida, Hirotaka Handa, Hiroshi Inoue, Takeo Saji, Hisashi Koike, Junki Nakamura, Seiji Sato, Yoshiharu Ueda, Yumi Suzuki, Fumihiko Matoba, Ryo Mineshita, Masamichi Cancers (Basel) Article SIMPLE SUMMARY: The gold standard for genetic panel test samples is considered to be tissue specimens. However, in clinical practice, tissue specimens are often unavailable. Therefore, using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we enrolled patients who underwent diagnostic procedures to evaluate analysis accuracy, nucleic acid yield, and quality using cytological specimens. Cytological specimens were suitable for both nucleic acid yield and specimen quality due to the ease of collection and processing. Cytological sample analysis detected gene mutations in 68.7% of lung adenocarcinomas, and these samples were consistent with companion diagnostic tests 99.5% of the time. Moreover, the allele frequency of gene mutations in cytological specimens showed a high correlation with tissue specimens. This is the first study to prospectively evaluate the feasibility of a lung cancer gene panel test using cytological specimens. ABSTRACT: Background: Genetic panel tests require sufficient tissue samples, and therefore, cannot always be performed. Although collecting cytological specimens is easier than tissue collection, there are no validation studies on the diagnostic accuracy of lung cancer gene panel tests using cytology samples. Methods: Using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we prospectively enrolled consecutive patients who underwent diagnostic procedures. We evaluated the analysis accuracy rate, nucleic acid yield, and the quality of cytological specimens under brushing, needle aspiration, and pleural effusion. We then compared these specimens with collected tissue samples. Results: In 163 prospectively enrolled cases, nucleic acid extraction and analysis accuracy was 100% in cases diagnosed with adenocarcinoma. Gene mutations were found in 68.7% of cases with 99.5% (95% CI: 98.2–99.9) concordance to companion diagnostics. The median DNA/RNA yield and DNA/RNA integrity number were 475/321 ng and 7.9/5.7, respectively. The correlation coefficient of the gene allele ratio in 64 cases compared with tissue samples was 0.711. Conclusion: The success of gene analysis using cytological specimens was high, and the yield and quality of the extracted nucleic acid were sufficient for panel analysis. Moreover, the allele frequency of gene mutations in cytological specimens showed high correlations with tissue specimens. MDPI 2022-08-03 /pmc/articles/PMC9367394/ /pubmed/35954448 http://dx.doi.org/10.3390/cancers14153784 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Morikawa, Kei Kida, Hirotaka Handa, Hiroshi Inoue, Takeo Saji, Hisashi Koike, Junki Nakamura, Seiji Sato, Yoshiharu Ueda, Yumi Suzuki, Fumihiko Matoba, Ryo Mineshita, Masamichi A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens |
title | A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens |
title_full | A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens |
title_fullStr | A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens |
title_full_unstemmed | A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens |
title_short | A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens |
title_sort | prospective validation study of lung cancer gene panel testing using cytological specimens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367394/ https://www.ncbi.nlm.nih.gov/pubmed/35954448 http://dx.doi.org/10.3390/cancers14153784 |
work_keys_str_mv | AT morikawakei aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT kidahirotaka aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT handahiroshi aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT inouetakeo aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT sajihisashi aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT koikejunki aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT nakamuraseiji aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT satoyoshiharu aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT uedayumi aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT suzukifumihiko aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT matobaryo aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT mineshitamasamichi aprospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT morikawakei prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT kidahirotaka prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT handahiroshi prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT inouetakeo prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT sajihisashi prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT koikejunki prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT nakamuraseiji prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT satoyoshiharu prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT uedayumi prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT suzukifumihiko prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT matobaryo prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens AT mineshitamasamichi prospectivevalidationstudyoflungcancergenepaneltestingusingcytologicalspecimens |